Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study

Gazit, 2022, Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study, BMJ, 377, e071113, 10.1136/bmj-2022-071113 Romero-Ibarguengoitia, 2022, Analysis of immunization, adverse events, and efficacy of a fourth dose of BNT162b2 vaccine, Vaccines (Basel), 10, 1139, 10.3390/vaccines10071139 Munro, 2022, Lancet Infect Dis, 22, 1131, 10.1016/S1473-3099(22)00271-7 Štěpánek, 2021, Motivation to COVID-19 vaccination and reasons for hesitancy in employees of a Czech tertiary care hospital: a cross-sectional survey, Vaccines, 9, 863, 10.3390/vaccines9080863 Machingaidze, 2021, Understanding COVID-19 vaccine hesitancy, Nat Med, 27, 1338, 10.1038/s41591-021-01459-7 Pertwee, 2022, An epidemic of uncertainty: rumors, conspiracy theories and vaccine hesitancy, Nat Med, 28, 456, 10.1038/s41591-022-01728-z Couzin-Frankel, 2022, Global project gears up to study vaccine safety, Science, 376, 227, 10.1126/science.abq4273 Mofaz, 2022, Self-reported and physiologic reactions to third BNT162b2 mRNA COVID-19 (booster) vaccine dose, Emerg Infect Dis, 28, 1375, 10.3201/eid2807.212330 Gepner, 2022, Utilizing wearable sensors for continuous and highly-sensitive monitoring of reactions to the BNT162b2 mRNA COVID-19 vaccine, Commun Med (Lond), 2, 27, 10.1038/s43856-022-00090-y Quer, 2022, Inter-individual variation in objective measure of reactogenicity following COVID-19 vaccination via smartwatches and fitness bands, NPJ Digit Med, 51, 49, 10.1038/s41746-022-00591-z Oved, 2021, Differential effects of COVID-19 lockdowns on well-being: interaction between age, gender and chronotype, J R Soc Interface, 18, 20210078, 10.1098/rsif.2021.0078 Perez, 2019, Large-scale assessment of a smartwatch to identify atrial fibrillation, N Engl J Med, 381, 1909, 10.1056/NEJMoa1901183 Mishra, 2020, Pre-symptomatic detection of COVID-19 from smartwatch data, Nat Biomed Eng, 4, 1208, 10.1038/s41551-020-00640-6 Alavi, 2021, Real-time alerting system for COVID-19 and other stress events using wearable data, Nat Med, 28, 175, 10.1038/s41591-021-01593-2 Chapin-Bardales, 2021, Reactogenicity following receipt of mRNA-Based COVID-19 vaccines, JAMA, 325, 2201, 10.1001/jama.2021.5374 Mathioudakis, 2021, Self-reported real-world safety and reactogenicity of COVID-19 vaccines: a vaccine recipient survey, Life (Basel, Switzerland), 3, 249 Polack, 2020, Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine, N Engl J Med, 383, 2603, 10.1056/NEJMoa2034577 Barda, 2021, Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting, N Engl J Med, 385, 1078, 10.1056/NEJMoa2110475 Wong, 2022, Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases, Lancet, 399, 2191, 10.1016/S0140-6736(22)00791-7 Rothman, 2012 Sáez-Llorens, 2021, Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials, Lancet, 397, 27, 10.1016/S0140-6736(20)32540-X Troiano, 2021, Vaccine hesitancy in the era of COVID-19, Public Health, 194, 245, 10.1016/j.puhe.2021.02.025 Chen, 2019, Impact of changes in heart rate with age on all-cause death and cardiovascular events in 50-year-old men from the general population, Open Hear, 6, e000856, 10.1136/openhrt-2018-000856 Raisi-Estabragh, 2020, Age, sex and disease-specific associations between resting heart rate and cardiovascular mortality in the UK BIOBANK, PLoS One, 15, e0233898, 10.1371/journal.pone.0233898 Feikin, 2022, Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression, Lancet, 399, 924, 10.1016/S0140-6736(22)00152-0